{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-010809","form_type":"8-K","ticker":"ADVB","cik":"0001941029","company_name":"Advanced Biomed Inc.","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.833359+00:00","generated_at":"2026-05-16T05:45:46.027925+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Advanced Biomed raises $248k via private placement of 4M shares at $0.062","bullets":["Issued 4,000,000 shares of common stock at $0.062/share for total proceeds of $248,000.","Securities Purchase Agreement entered Jan 28, 2026, closed Jan 29, 2026.","Private placement exempt from registration under Section 4(a)(2) of Securities Act and Regulation S."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-010809","json":"https://secwatch.observer/filing/0001213900-26-010809.json","markdown":"https://secwatch.observer/filing/0001213900-26-010809.md","text":"https://secwatch.observer/filing/0001213900-26-010809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/ea0274958-8k_advanced.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:45:46.027925+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"76decbeeafc25e73018a759b35266020e969f835","claim":"Advanced Biomed Inc. issued 4,000,000 shares of common stock to certain investors for $0.062 per share for a total purchase price of $248,000.","evidence_excerpt":"On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) relating to the issuance and sale of 4,000,000 shares of common stock (the “Purchased Shares”), par value $0.001 per share, of the Company (the “Common Stock”), at $0.062 per share for a total purchase price of $248,000","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"4,000,000 shares"},{"label":"Purchaser","value":"certain investors"},{"label":"Consideration","value":"$0.062 per share for a total purchase price of $248,000"}],"fact_type":"equity_issuance"},{"claim_id":"5b3c2921355c6884a106a187a421a0a477ebb93a","claim":"Advanced Biomed Inc. entered into Securities Purchase Agreement with certain investors valued at $248,000 (effective 2026-01-28).","evidence_excerpt":"On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) relating to the issuance and sale of 4,000,000 shares of common stock (the “Purchased Shares”), par value $0.001 per share, of the Company (the “Common Stock”), at $0.062 per share for a total purchase price of $248,000 (the “Purchase Price”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"$248,000"},{"label":"Effective","value":"2026-01-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}